MRK
Merck & Co., Inc.F2515-min delayed · EOD close148.36 −0.78% downas of 2026-11-02mkt cap $366B
Pharmaceutical Preparations · SIC 2834 · CIK 0000310158
Quality score
25/100
F
Growth14
Business quality20
missing: grossMargin, operatingMargin
Financial healthno data
missing: debtToEquity, cashToLiabilities
Valuation40
Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.
The read
Weak on most measures
Uneven
Strongest on valuation (40), weakest on growth (14). The composite is the mean of the sub-scores that could be computed. 4 inputs were unavailable in the filings, so the score reflects what was reported.
Revenue growth
3.7%
year over year
Earnings growth
-81.5%
year over year